Cargando…

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma

SIMPLE SUMMARY: Osteosarcoma (OS), the most common primary bone tumor, mainly affects children and adolescents. Unfortunately, in some cases, the absence of response to chemotherapy agents is observed, leading to metastases development and death of the patient. Resistance is one of the biological pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchandet, Louise, Lallier, Morgane, Charrier, Céline, Baud’huin, Marc, Ory, Benjamin, Lamoureux, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915189/ https://www.ncbi.nlm.nih.gov/pubmed/33567616 http://dx.doi.org/10.3390/cancers13040683

Ejemplares similares

Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
por: Lallier, Morgane, et al.
Publicado: (2021)

Origin and Therapies of Osteosarcoma
por: Moukengue, Brice, et al.
Publicado: (2022)

Ribosomopathies: New Therapeutic Perspectives
por: Orgebin, Emilien, et al.
Publicado: (2020)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
por: Lamoureux, Francois, et al.
Publicado: (2014)

Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas
por: Jacques, Camille, et al.
Publicado: (2020)

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model
por: Moukengue, Brice, et al.
Publicado: (2020)

Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells
por: Tesfaye, Robel A., et al.
Publicado: (2023)

miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors
por: Jacques, Camille, et al.
Publicado: (2016)

Molecular Alterations Associated with Osteosarcoma Development
por: Ando, Kosei, et al.
Publicado: (2012)

The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway
por: Rodriguez Calleja, Lidia, et al.
Publicado: (2022)

Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma
por: Georges, Steven, et al.
Publicado: (2018)

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
por: Jacques, Camille, et al.
Publicado: (2016)

Ewing sarcoma from molecular biology to the clinic
por: Dupuy, Maryne, et al.
Publicado: (2023)

Preliminary Results of the “Capasquelet” Technique for Managing Femoral Bone Defects—Combining a Masquelet Induced Membrane and Capanna Vascularized Fibula with an Allograft
por: Combal, Alexis, et al.
Publicado: (2021)

Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells
por: Faraahi, Z., et al.
Publicado: (2019)

Corrigendum to “Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells” [Bone 122 (May 2019) 82–92]
por: Faraahi, Z., et al.
Publicado: (2019)

Interaction of Cutibacterium ( formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development
por: Aubin, Guillaume Ghislain, et al.
Publicado: (2017)

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
por: Gobin, Bérengère, et al.
Publicado: (2014)

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification
por: Espitia, Olivier, et al.
Publicado: (2018)

Recent Insights into Therapy Resistance in Osteosarcoma
por: Prudowsky, Zachary D., et al.
Publicado: (2020)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
por: Hattinger, Claudia Maria, et al.
Publicado: (2023)

Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy
por: Cersosimo, Francesca, et al.
Publicado: (2020)

Nanocarriers in Veterinary Medicine: A Challenge for Improving Osteosarcoma Conventional Treatments
por: Sapino, Simona, et al.
Publicado: (2022)

Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
por: Ory, B, et al.
Publicado: (2008)

Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration
por: Odri, Guillaume, et al.
Publicado: (2014)

Under-sampling in epilepsy: Limitations of conventional EEG
por: Baud, Maxime O., et al.
Publicado: (2020)

Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy
por: Que, Ziyuan, et al.
Publicado: (2023)

Adjuvant Biophysical Therapies in Osteosarcoma
por: Carina, Valeria, et al.
Publicado: (2019)

An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains
por: Salazar, Sara B., et al.
Publicado: (2020)

Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma
por: Lu, Ko-Hsiu, et al.
Publicado: (2019)

Molecular Mechanisms of Canine Osteosarcoma Metastasis
por: Wilk, Sylwia S., et al.
Publicado: (2021)

Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
por: Nirala, Bikesh K., et al.
Publicado: (2023)

Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study
por: Maurin, Corantin, et al.
Publicado: (2022)

Conventional osteosarcoma of the mandible: Report of a rare case
por: Mirmohammad Sadeghi, Hassan, et al.
Publicado: (2021)

Chemotherapy Regimens for Non-Metastatic Conventional Appendicular Osteosarcoma: A Literature Review Based on the Outcomes
por: Soares do Brito, Joaquim, et al.
Publicado: (2023)

Forecast of actin-binding proteins as the oncotarget in osteosarcoma – a review of mechanism, diagnosis and therapy
por: Fu, Yucheng, et al.
Publicado: (2018)

An overview of resistance to chemotherapy in osteosarcoma and future perspectives
por: Garcia-Ortega, Dorian Yarih, et al.
Publicado: (2022)

Research progress in the mechanism and treatment of osteosarcoma
por: Bian, Jichao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dom3dde0b73t05dm3nqhdi6mu9